Lysogene vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $4 M for Lysogene, 22533 times as much (market caps of Dec 25, 2022 for Lysogene and Oct 30, 2026 for Moderna, Inc.). Lysogene's value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $4 M for Lysogene in the year to December 2021.
- Both made a net loss: $16 M for Lysogene and $2.8 B for Moderna, Inc.
- Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -364.9% for Lysogene.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Lysogene LYS.PA | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇫🇷 France | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $4 M* | $90.1 B |
| Revenue | $4 M | $1.9 B |
| Net income | $-16 M▲ best | $-2.8 B |
| Employees | — | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Dec 2022 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Lysogene or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $4 M for Lysogene, 22533 times as much (market caps of Dec 25, 2022 for Lysogene and Oct 30, 2026 for Moderna, Inc.). Lysogene's value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, Lysogene or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $4 M for Lysogene in the year to December 2021. Both made a net loss: $16 M for Lysogene and $2.8 B for Moderna, Inc.
Which is more profitable, Lysogene or Moderna, Inc.?
Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -364.9% for Lysogene.
More about Lysogene
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.